One may naturally predict that the therapeutic activation of the APN signaling pathway by pharmacological means may be ideal for bed-ridden elderly to prevent the pathological consequences of extreme inactivity from T2DM, vascular and other metabolic diseases. The gene discussed is ANPEP; the disease is type 2 diabetes mellitus.